Navigation Links
Human Genome Sciences Announces Third Quarter 2007 Financial Results and Key Developments
Date:11/1/2007

become a breakthrough treatment for SLE. Phase 2 results through 2.5 years of LymphoStat-B treatment will be presented at the annual meeting of the American College of Rheumatology in Boston, November 6-11, 2007.

ABthrax(TM): Meeting Contract Milestones

HGS has met all milestones to date under its contract with the U.S. Government to supply 20,000 doses of ABthrax (raxibacumab) to the Strategic National Stockpile. The Company is working to conduct the additional clinical and laboratory studies required to support the filing of a Biologics License Application (BLA), and is on track to begin delivery to the stockpile in 2008. HGS expects to receive $165 million under the contract, with most of the revenue to come in 2008 and with the remainder to come when ABthrax is licensed by the FDA.

TRAIL Receptor Antibodies: Clinical and Preclinical Results

In October 2007, HGS presented new clinical and preclinical evidence of the anti-tumor activity and tolerability of the Company's TRAIL receptor antibodies for the treatment of cancer at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in San Francisco. The results of a Phase 1b trial demonstrated that HGS-ETR2 (lexatumumab) was safe and well tolerated in combination with four different standard chemotherapy regimens in patients with a wide range of cancer types. Objective responses were reported for two patients, and stable disease was observed in 22 patients.

The Company also presented preclinical data demonstrating that HGS-ETR1 (mapatumumab) and HGS-ETR2 in combination with chemotherapy synergistically enhanced anti-tumor activity in cholangiocarcinoma (cancer of the bile ducts). In a xenograft model of cholangiocarcinoma, the results demonstrated that HGS- ETR1 and either co-treatment or pre-treatment with cisplatin and gemcitabine were more effective than chemotherapy or HGS-ETR1 alone.

HGS is currently enrolling a randomized Phase 2 trial of H
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Human Primary Preadipocytes and Differentiated Adipocytes
2. Low Abundance cDNA Cloned Using Stratagenes Human Universal cDNA Library
3. Control RT-PCR Primers for Human Gene Transcripts with Varying Abundance
4. New Mammalian Expression Vectors Employ Stable, High-Level Fluorescence Humanized Renilla GFP Reporter
5. Human Universal cDNA Library Array I
6. Map and Link Human Genetic Disorders with SSLP Analysis
7. RT-PCR Primer Sets for Human and Mouse Mismatch Repair Genes
8. Transfection of Green Fluorescent Protein into Human Adrenalcarcinoma Cells
9. Fluorescence-Based Single-Tube Assays to Rapidly Detect Human Gene Mutations
10. Improve Lipid- or Calcium Phosphate-Mediated Transfection of Human Dermal Fibroblasts
11. Sequence-Validated and Expression-Tested Human cDNA in a Dual Expression Vector
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/23/2014)... 2014 Dr. Carl Peck, ... today that Janet B. Arrowsmith, MD, has joined ... Partners Premier Experts are top tier consultants whose ... extraordinary value to the company’s clients. Premier Experts ... help clients successfully develop their medical products, pursue ...
(Date:8/22/2014)... Dallas, Texas (PRWEB) August 23, 2014 ... on the current state of the Papain industry ... basic overview of the industry, including definitions, applications ... Chinese domestic market analysis are provided with a ... of the market. A comparison between the international ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 Today the Academy ... the United States Court of Appeals for the D.C. Circuit ... Aircraft published in the Federal Register on June 25, 2014. ... is contrary to the text and intent of the FAA ... violates Congress’ specific prohibition on any new rules or regulations ...
(Date:8/22/2014)... - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced results ... Biorem,s complete 2014 second quarter financial statements and MD&A have been filed ... June 30, , Six-months ended June 30, ( in CDN$,000 ... , 2014 , 2013 Revenue , 2,459 ... Gross profit , 56 , 1,485 , ...
Breaking Biology Technology:Noted Epidemiologist and Former FDA Deputy Director Janet B. Arrowsmith, MD, Joins NDA Partners as a Premier Expert Consultant 2Papain Industry Global & China Development Trend and Proposals Analysis Research Report Available at DeepResearchReports.com 2Papain Industry Global & China Development Trend and Proposals Analysis Research Report Available at DeepResearchReports.com 3AMA Files Petition for Review of FAA’s Interpretive Rule 2Biorem Reports 2014 Second Quarter Results 2Biorem Reports 2014 Second Quarter Results 3
... Two physicists from The University of Manchester who discovered ... for their work. , Professor Andre Geim FRS and ... Nanotechnology have been awarded the prestigious Europhysics Prize for ... reveal its remarkable electronic properties. , Graphene is a ...
... Inc.,(Nasdaq: MEDX ) announced today that it is ... at 9:10 a.m. Eastern Time on,Thursday, September 4, 2008. ... in the Investor Relations section of the Medarex website ... will be available,following the event., About Medarex, ...
... presentations included Resverlogix data, TSX Exchange Symbol: ... Corp.,("Resverlogix" or the "Company") (TSX:RVX) is pleased to ... pertaining to its lead compound,RVX-208, at the European ... titled "RVX-208 a novel small molecule that increases,apolipoprotein ...
Cached Biology Technology:Graphene pioneers follow in Nobel footsteps 2Medarex to Present at the Thomas Weisel Partners Healthcare Conference 2ApoA-I Data Presented at European Society of Cardiology Congress 2
(Date:8/21/2014)... they are the ultimate source of all organic matter ... on algae, too, to suck up climate-warming carbon dioxide ... of the ocean. Now, by using a combination of ... that viruses infecting those algae are driving the life-and-death ... stays essentially the same, and this has important implications ...
(Date:8/21/2014)... that has implications for life in other extreme environments, ... system, LSU Associate Professor of Biological Sciences Brent Christner ... or NSF, this week published a paper confirming that ... 800 meters (2600 feet) beneath the surface of the ... that more than 400 subglacial lakes and numerous rivers ...
(Date:8/21/2014)... international standards process, will be available soon and will ... published in the OnlineFirst version of Nutrition in ... of the American Society for Parenteral and Enteral Nutrition ... of misconnection that can be harmful and even fatal ... join medical devices, components, and accessories to deliver fluids ...
Breaking Biology News(10 mins):Viruses take down massive algal blooms, with big implications for climate 2800 meters beneath Antarctic ice sheet, subglacial lake holds viable microbial ecosystems 2800 meters beneath Antarctic ice sheet, subglacial lake holds viable microbial ecosystems 3800 meters beneath Antarctic ice sheet, subglacial lake holds viable microbial ecosystems 4New feeding tube connectors will improve patient safety 2
... cities is often an overlooked resource. Years of manufacturing or ... scare residents away from using the land. As the local ... desire to grow food in cities with the fear that ... 10:35 am, Kristen McIvor of the Pierce Conservation District will ...
... STATION Dr. Xiuren Zhang, a biochemist and ... has been awarded almost $1.3 million from the National ... and plant stem cells, which ultimately could help breed ... science foundation,s CAREER program, which is given in "support ...
... Microbial fuel cells, chemical sensors for your iPhone, ... faster-charging batteries, safer nuclear power, and new crime scene ... on the science of materials, interfaces, and processing. Detailed ... AVS 60th International Symposium & Exhibition will take place ...
Cached Biology News:Fostering community gardens in an area with historic soil contamination 2AgriLife researcher Xiuren Zhang receives National Science Foundation CAREER grant 2AVS science symposium in Long Beach Oct. 27 -- Nov. 2 2
Goat polyclonal to Ephrin B2 ( Abpromise for all tested applications). entrezGeneID: 1948 SwissProtID: P52799...
Pronase Reagent...
Mouse monoclonal [7E10] to C Peptide ( Abpromise for all tested applications). entrezGeneID: 3630 SwissProtID: P01308...
p38 MAP Kinase gamma Antibody Shipping Temperature: HOT Storage Temperature: -20C...
Biology Products: